INITIATION OF COVERAGE BY IN EXTENSO
PRICE TARGET AT 9.76 EUROS
Villejuif, France, January 11, 2023 at 6:00 p.m. CET
– PREDILIFE (Euronext Growth: ALPRE FR0010169920), specialist in innovative pathology risk prediction solutions for personalized medicine, announces the initiation of coverage of its share by In Extenso Financement & Marché, an investment bank dedicated to VSEs and growing SMEs.
In its initiation study published on January 11, 2023, In Extenso Financement & Marché begins monitoring the stock with a strong buy recommendation and values PREDILIFE at €9.76 per share (study available here).
The research contract signed with In Extenso Financement & Marché is part of PREDILIFE’s desire to strengthen its stock market visibility with professional and individual investors.
About PREDILIFE
PREDILIFE is a pioneer in the design and development of predictive tests intended to prevent the main diseases. It uses artificial intelligence methods applied to clinical and genetic medical data in a secure legal framework. The prediction of these individual risks makes it possible to propose a personalized monitoring protocol and earlier identification of pathologies.
|
contacts PREDILIFE Investor Relations Stephane Ragusa Chairman and CEO |
CAPVALUE Press Relations 01 80 81 50 00 |
* This publication was written by In Extenso. It is issued for information purposes only and in no way constitutes a solicitation of an order to buy or sell the securities mentioned therein. The information contained in this publication and all opinions expressed herein are based on sources believed to be reliable. However, In Extenso does not in any way guarantee the accuracy or completeness of this information and no one can rely on it. All opinions, projections and/or estimates contained in this publication reflect the judgment of In Extenso as of the date of this publication and may be subject to change without notice. This publication is intended solely for the information of investors classified as “professional” or “eligible counterparty” within the meaning of MiFID and who are expected to make their own investment decision without relying inappropriately on this publication. If a “non-professional” individual comes into possession of this document, he should not base his possible investment decision solely on the basis of said document but should consult his own advice. Investors should make their own judgment as to the suitability of an investment in any transferable security mentioned in this publication taking into account the merits and risks attached thereto, their own investment strategy and their legal situation, fiscal and financial. Historical performance is in no way a guarantee for the future.
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
m2hrZppsY2uZmmlplZWWnGpoZ2mSl5HIamSck2RxZJ2Xb3FkmZpnacqXZnBplWVo
– To check this key:
https://www.security-master-key.com.
Regulated information:
Inside information:
– Other press releases
Full and original press release in PDF format:
https://www.actusnews.com/news/78002-predilife-cp-mise-a-disposition-note-in-extenso-110123.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com